Arcturus Therapeutics Holdings Inc.

• Arcturus Therapeutics Holdings Inc. Estimates – NASDAQ:ARCT
  TradingView · 23 Oct 2026
• Arcturus Therapeutics Slides to $10.26 as ARCT Tests Key Support Zone - Money Flow
  www.siam.in · 23 Oct 2026
• Arcturus Therapeutics unveils LUNAR 2.0 lipid delivery system and updates OTC deficiency program
  Traders Union · 21 Oct 2026
• Precision Trading with Arcturus Therapeutics Holdings Inc. (ARCT) Risk Zones
  Stock Traders Daily · 17 Oct 2026
• Transcript: Arcturus Therapeutics Q2 2026 Earnings Conference Call
  Benzinga · 14 Oct 2026
• Arcturus Therapeutics (ARCT) Receives a Buy from Leerink Partners
  The Globe and Mail · 10 Oct 2026
• Arcturus Therapeutics Shares Rise After OTC Deficiency Data, Citigroup Upgrade
  marketscreener.com · 24 Sep 2026
• Arcturus stock upgraded to Buy at Citi (ARCT:NASDAQ)
  Seeking Alpha · 24 Sep 2026
• US mRNA player Arcturus buys Belgian biotech MyNeo
  Dealroom · 24 Sep 2026
• Arcturus Therapeutics Releases ARCT-810 Phase 2 Clinical Results and mRNA Platform Update
  Kalkine Media · 23 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →